Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

6 results

Sort by

List item

Human medicine European public assessment report (EPAR): Capecitabine Accord

capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012, , Revision: 16, Authorised, Last updated: 10/12/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Medac (updated)

capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012, , Revision: 12, Authorised, Last updated: 25/04/2022
List item

Human medicine European public assessment report (EPAR): Capecitabine Teva

capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012, , Revision: 15, Authorised, Last updated: 08/09/2021
List item

Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)

capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012, , Revision: 13, Authorised, Last updated: 23/04/2021
List item

Human medicine European public assessment report (EPAR): Picato

Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012, , Revision: 10, Withdrawn, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Xarelto

rivaroxaban, Arthroplasty, Replacement; Venous Thromboembolism
Date of authorisation: 30/09/2008, , Revision: 36, Authorised, Last updated: 13/12/2021